Position in ABUS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$84,951,860
-$31,559,797 QoQ
Shares Held
17,698,305
-31.6% QoQ
Ownership
8.95%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 175 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 96%
Shared 4%
None 0%
Common Shares in ABUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,848,792 across 523 Biotechnology names. ABUS ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in ABUS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,951,860 | 17,698,305 | Shares | Defined | 2026-08-13 | |
| 2026-06-30 | $83,459,510 | 17,387,398 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $116,511,657 | 25,891,480 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $128,440,349 | 26,702,776 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $111,005,776 | 24,450,612 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $74,661,760 | 24,162,383 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $83,035,434 | 23,792,389 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $73,859,220 | 22,586,918 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $83,577,533 | 21,708,451 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $64,767,223 | 20,960,268 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $22,782,161 | 8,830,297 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $17,460,279 | 6,984,112 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $10,680,091 | 5,261,130 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $11,684,677 | 5,080,296 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,794,295 | 4,882,607 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $563,609 | 241,894 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $404,929 | 212,006 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $593,362 | 218,954 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $587,598 | 197,181 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $929,735 | 239,007 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $948,877 | 221,184 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $884,095 | 291,781 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,764,134 | 1,130,371 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,049,036 | 1,422,264 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,107,410 | 2,909,716 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $6,103,437 | 3,353,537 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,067,476 | 2,047,008 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||